Top Markets
Coin of the day
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Rangering i aksjer #31074
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Aksjekurs
$0.404
Markedsverdi
$14.28M
Endring (1 dag)
-10.42%
Endring (1 år)
-67.68%
Land
IL
Handel NeuroSense Therapeutics Ltd. (NRSN)

Kategori

Aksjeprishistorikk for NeuroSense Therapeutics Ltd. (NRSN)
Høyeste sluttskurs: $0.47 den 2026-08-01

Laveste sluttskurs: $3.04 den 2021-12-01
Aksjeprishistorikk for NeuroSense Therapeutics Ltd. fra 2021 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -1.04%
2025 -17.69%
2024 31.68%
2023 -42.23%
2022 -51.82%
2021 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$528.88 35.65%
US
$1.00K 51.38%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE